MPLT
MapLight Therapeutics
MPLT
MPLT
78 hedge funds and large institutions have $494M invested in MapLight Therapeutics in 2026 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6.44% more ownership
Funds ownership: 50.84% → 57.28% (+6.4%)
5% more funds holding
Funds holding: 74 → 78 (+4)
Holders
78
Holding in Top 10
9
Calls
–
Puts
–
Top Buyers
| 1 | +$12.1M | |
| 2 | +$4.44M | |
| 3 | +$4.37M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.64M |
Top Sellers
| 1 | -$9.66M | |
| 2 | -$5.76M | |
| 3 | -$3.34M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.17M |
| 5 |
Lazard Asset Management
New York
|
-$1.17M |
